Fellowbook News

.@utswcancer @DJSiegwart evidence that modulating tissue stiffness can enhance gene editing in tumors – offering a new strategy for lipid nanoparticles plus gene editing to treat cancer. @NatureNano #Biochemistry https://go.nature.com/37J4rfv

Let's be open & transparent: Less than 1/3 of nominations for AIMBE 2023 Fellows received are for women. With the nomination deadline looming next week (Jun 30), do your part and nominate! These stats will only improve with your help and it's not too late! https://aimbe.org/college-of-fellows/nominations-election/

1/ In her new role, Lydia Contreras will lead the advancement of @UTAustin's Strategic Plan for Faculty Diversity, Equity, and Inclusivity. https://bit.ly/3y6z5tN

Dr. Cato T. Laurencin Elected to the European Academy of Sciences https://today.uconn.edu/2022/06/dr-cato-t-laurencin-elected-to-the-european-academy-of-sciences/

$2.38M to test nano-engineered brain cancer treatment in mice

Congratulations to our @TexasChE colleague Lydia Contreras @Contreras_Lab who was appointed the new Vice Provost for Faculty Diversity, Equity, and Inclusivity Lydia will lead the advancement of UT's Strategic Plan for Faculty Diversity, Equity, and Inclusivity. Congratulations!

Two weeks remaining to submit your nominations for the AIMBE College of Fellows Class of 2023! https://aimbe.org/college-of-fellows/nominations-election/

Nanoparticle sensor can distinguish between viral and #bacterialpneumonia @MIT @PNASNews https://phys.org/news/2022-06-nanoparticle-sensor-distinguish-viral-bacterial.html

Investigators unlocking mysteries of cell-based therapies

More: https://buff.ly/3aDK3Oa

#Ophthalmology #OphthoTwitter #CellTherapy #Therapeutics #Cornea

Load More...


AIMBE’s College of Fellows is comprised of more than 2,000 individuals who have made significant contributions to the medical and biological engineering (MBE) community in academia, industry, government, and education that have transformed the world.


AIMBE’s 110 member universities offering biological and engineering sciences focus on developing and applying new knowledge about biology and engineering in ways that benefit humankind – in fields ranging from medicine to agriculture and beyond.


AIMBE’s sixteen scientific organizations in medical and biological engineering coordinate activities of member societies with the activities of academia, government, the health care sector, industry and the public and private biomedical communities.


Members of the Industry Council – the companies and key corporate leaders of the bioengineering revolution – identify and act on common interests that will further advance medical and biological engineering and enhance public health and welfare.